banner-for-pr

Thursday, October 27, Senate Finance Committee Chairman Orrin Hatch, R-UT, and Ranking Member Ron Wyden, D-OR, along with Senators Johnny Isakson, R-GA, and Mark Warner, D-VA, co-chairs of the Finance Committee Chronic Care Working Group, released a discussion draft with bipartisan proposals to improve health outcomes for Medicare beneficiaries living with chronic conditions.  Among the recommendations is the expansion of the Medicare Advantage V-BID demonstration to plans in any state:

Section 301. Adapting Benefits to Meet the Needs of Chronically Ill Medicare Advantage Enrollees Under Medicare Advantage (MA) private health plans are paid a per-person monthly amount to provide all Medicare-covered benefits (except hospice) to beneficiaries who enroll. Unlike original Medicare, where providers are paid for each item or service provided to a beneficiary, an MA plan receives the same capitated monthly payment regardless of how many or few services a beneficiary actually uses. The plan is at-risk if aggregate costs for its enrollees exceed program payments and beneficiary cost sharing; conversely, in general, the plan can retain savings if aggregate enrollee costs are less than program payments and cost sharing. Currently, an MA plan must offer the same benefit package to all of its enrollees. The Centers for Medicare and Medicaid Innovations (CMMI) is currently testing a model to allow greater flexibility for an MA plan to meet the needs of chronically ill enrollees. This section would expand the testing of the CMMI Value-Based Insurance Design (VBID) Model to allow an MA plan in any state to participate in the model during the testing phase to determine whether savings are achieved without negatively impacting quality.

This growing bipartisan support and expanded role of V-BID principles in public and private payers builds on H.R. 5652 “Access to Better Care Act of 2016.”  This bipartisan bill provides high-deductible health plans the flexibility to provide coverage for services that manage chronic disease prior to meeting the plan deductible.

A. Mark Fendrick, MD, developer of the V-BID concept and Director of the University of Michigan V-BID Center, is available for questions or comments.  Learn more about V-BID in Medicare Advantage here.

Medicare Advantage White Paper      Medicare Advantage 1-Pager      Medicare Advantage Infographic